Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world

ObjectiveTo comprehensively examine the incidence and mortality of malignant neoplasms of bone and articular cartilage (MNBAC) in China compared with the world, as well as its age-specific patterns and sex disparities.MethodsThe MNBAC burden in China and the world was systematically assessed from 19...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng Chen, Xu Zheng, Yi Zhang, ZhenDong Li, Bing Li, YunFeng Yang, WeiBin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1629679/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849232641483603968
author Cheng Chen
Xu Zheng
Yi Zhang
ZhenDong Li
Bing Li
YunFeng Yang
WeiBin Zhang
author_facet Cheng Chen
Xu Zheng
Yi Zhang
ZhenDong Li
Bing Li
YunFeng Yang
WeiBin Zhang
author_sort Cheng Chen
collection DOAJ
description ObjectiveTo comprehensively examine the incidence and mortality of malignant neoplasms of bone and articular cartilage (MNBAC) in China compared with the world, as well as its age-specific patterns and sex disparities.MethodsThe MNBAC burden in China and the world was systematically assessed from 1990 to 2021 based on the Global Burden of Disease 2021, including incidence and mortality data. The estimated annual percentage change was calculated. The pattern of age and gender distribution was carried out. The future trends of MNBAC incidence and mortality through 2030 were predicted using the Bayesian age-period-cohort model.ResultsFrom 1990 to 2021, China experienced rising trends in both the incidence and mortality of MNBAC, increasing at a much faster pace than the world. Before 2005, crude incidence and mortality rates in China increased but plateaued thereafter. In contrast, age-standardized rates displayed a decreasing trend from 2005 onward. During this period, the world experienced relatively stable incidence and mortality rates. The incidence and mortality rates of MNBAC increase with age. The MNBAC burden is higher in males. The rise in incidence and mortality rate in China was predominantly in the elderly. The burden prediction for MNBAC to 2030 showed that China would experience a more significant drop in incidence and mortality rates for MNBAC, along with a decrease in the incidence and mortality cases.ConclusionsFrom 1990 to 2021, the MNBAC burden in China remains heavy, with incidence and mortality increasing much faster than in the world. The projection results indicate a promising outlook for the future, which is encouraging news. Men and the elderly should be the key target for the public health policies of MNBAC.
format Article
id doaj-art-a3b5914f5bbb41f8a7b13e3d6dbc3567
institution Kabale University
issn 2234-943X
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-a3b5914f5bbb41f8a7b13e3d6dbc35672025-08-21T04:10:21ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-08-011510.3389/fonc.2025.16296791629679Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with worldCheng Chen0Xu Zheng1Yi Zhang2ZhenDong Li3Bing Li4YunFeng Yang5WeiBin Zhang6Department of Orthopedics, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Bone and Joint Surgery, Department of Orthopedics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Orthopaedics, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, ChinaDepartment of Orthopaedics, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, ChinaDepartment of Orthopaedics, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, ChinaObjectiveTo comprehensively examine the incidence and mortality of malignant neoplasms of bone and articular cartilage (MNBAC) in China compared with the world, as well as its age-specific patterns and sex disparities.MethodsThe MNBAC burden in China and the world was systematically assessed from 1990 to 2021 based on the Global Burden of Disease 2021, including incidence and mortality data. The estimated annual percentage change was calculated. The pattern of age and gender distribution was carried out. The future trends of MNBAC incidence and mortality through 2030 were predicted using the Bayesian age-period-cohort model.ResultsFrom 1990 to 2021, China experienced rising trends in both the incidence and mortality of MNBAC, increasing at a much faster pace than the world. Before 2005, crude incidence and mortality rates in China increased but plateaued thereafter. In contrast, age-standardized rates displayed a decreasing trend from 2005 onward. During this period, the world experienced relatively stable incidence and mortality rates. The incidence and mortality rates of MNBAC increase with age. The MNBAC burden is higher in males. The rise in incidence and mortality rate in China was predominantly in the elderly. The burden prediction for MNBAC to 2030 showed that China would experience a more significant drop in incidence and mortality rates for MNBAC, along with a decrease in the incidence and mortality cases.ConclusionsFrom 1990 to 2021, the MNBAC burden in China remains heavy, with incidence and mortality increasing much faster than in the world. The projection results indicate a promising outlook for the future, which is encouraging news. Men and the elderly should be the key target for the public health policies of MNBAC.https://www.frontiersin.org/articles/10.3389/fonc.2025.1629679/fullmalignant neoplasm of bone and articular cartilageChinaepidemiologyincidencemortalityGBD 2021
spellingShingle Cheng Chen
Xu Zheng
Yi Zhang
ZhenDong Li
Bing Li
YunFeng Yang
WeiBin Zhang
Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world
Frontiers in Oncology
malignant neoplasm of bone and articular cartilage
China
epidemiology
incidence
mortality
GBD 2021
title Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world
title_full Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world
title_fullStr Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world
title_full_unstemmed Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world
title_short Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world
title_sort burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in china compared with world
topic malignant neoplasm of bone and articular cartilage
China
epidemiology
incidence
mortality
GBD 2021
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1629679/full
work_keys_str_mv AT chengchen burdenofmalignantneoplasmofboneandarticularcartilagefrom1990to2021anditspredictionsto2030inchinacomparedwithworld
AT xuzheng burdenofmalignantneoplasmofboneandarticularcartilagefrom1990to2021anditspredictionsto2030inchinacomparedwithworld
AT yizhang burdenofmalignantneoplasmofboneandarticularcartilagefrom1990to2021anditspredictionsto2030inchinacomparedwithworld
AT zhendongli burdenofmalignantneoplasmofboneandarticularcartilagefrom1990to2021anditspredictionsto2030inchinacomparedwithworld
AT bingli burdenofmalignantneoplasmofboneandarticularcartilagefrom1990to2021anditspredictionsto2030inchinacomparedwithworld
AT yunfengyang burdenofmalignantneoplasmofboneandarticularcartilagefrom1990to2021anditspredictionsto2030inchinacomparedwithworld
AT weibinzhang burdenofmalignantneoplasmofboneandarticularcartilagefrom1990to2021anditspredictionsto2030inchinacomparedwithworld